Back to overview

University of Connecticut Neurology

Residency · Hartford, CT

Sponsored by University of Connecticut School of Medicine · Director Daniyal Asad

Works by its people
2,649
Authors
164
First-author works
796
Citations
106,119
20112026

Topics

  • Acute Ischemic Stroke Management 230
  • Venous Thromboembolism Diagnosis and Management 104
  • Intracranial Aneurysms: Treatment and Complications 99
  • Amyotrophic Lateral Sclerosis Research 71
  • Migraine and Headache Studies 70
  • Multiple Sclerosis Research Studies 59
  • Epilepsy research and treatment 56
  • Glioma Diagnosis and Treatment 51
  • Cerebrovascular and Carotid Artery Diseases 41
  • Vascular Malformations Diagnosis and Treatment 40
  • Intracerebral and Subarachnoid Hemorrhage Research 36
  • Atrial Fibrillation Management and Outcomes 29

Most cited

  1. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.

    JAMA · 2023 · 730 citations · Christian Mouchati

  2. Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.

    The New England journal of medicine · 2022 · 755 citations · Jinsy Andrews

  3. A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.

    The New England journal of medicine · 2021 · 662 citations · Diego Ojeda

  4. Proteogenomic and metabolomic characterization of human glioblastoma.

    Cancer cell · 2021 · 549 citations · Alexis Demopoulos

  5. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021 · 246 citations · Francis DiMario

  6. APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies.

    Neurology · 2021 · 213 citations · Jamie Herrera

  7. Blood Pressure Management After Endovascular Therapy for Acute Ischemic Stroke: The BEST-II Randomized Clinical Trial.

    JAMA · 2023 · 107 citations · Shilpi Mittal, Tapan Mehta, Neeharika Krothapalli, Matthew Jaffa

  8. Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study.

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022 · 153 citations · Jinsy Andrews